Shoulder Surgery Traditional vs Accelerated Rehabilitation Trial
Launched by MANCHESTER UNIVERSITY NHS FOUNDATION TRUST · Apr 10, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different rehabilitation approaches for patients who have had surgery to repair a rotator cuff tear in the shoulder. After the surgery, participants will be randomly assigned to either a standard rehabilitation program, which requires using a sling for six weeks and includes a set exercise plan, or an accelerated rehabilitation program that allows them to skip the sling and start exercises right away. The goal is to see if there's any difference in recovery and shoulder function between the two groups after six months.
To be eligible for this trial, participants should be adults over 40 years old with a specific type of rotator cuff tear. Some people may not qualify if they have other serious shoulder problems or cannot follow post-surgery instructions. Throughout the study, patients will be monitored for pain, shoulder movement, and overall recovery, and they will have an MRI scan six months after surgery to check how well the repair has held up. This trial is important because it could help determine the best way to rehabilitate after shoulder surgery, potentially leading to better outcomes for patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged over 40 with a degenerate full-thickness posterosuperior rotator cuff tear undergoing arthroscopic rotator cuff repair (+/- concomitant procedures such as biceps tenotomy and subacromial decompression).
- Exclusion Criteria:
- • Other musculoskeletal disease affecting same limb
- • Massive rotator cuff tear
- • Subscapularis tear
- • Incomplete cuff repair
- • Repair under tension
- • Non-English speaker
- • Inability to follow postoperative instructions / restrictions
About Manchester University Nhs Foundation Trust
Manchester University NHS Foundation Trust is a leading healthcare organization dedicated to delivering exceptional patient care and advancing medical research. As an integral part of the UK's National Health Service, the Trust encompasses a range of hospitals and services, fostering innovation in clinical research and trials. With a strong emphasis on collaboration and excellence, Manchester University NHS Foundation Trust is committed to improving health outcomes through rigorous scientific investigation and the translation of research findings into practice, ensuring that patients benefit from the latest advancements in medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Manchester, , United Kingdom
Patients applied
Trial Officials
Mrs K Rhodes
Study Director
Manchester University Foundation Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials